Murine lethal toxic shock caused by intranasal administration of staphylococcal enterotoxin B

Toxicologic Pathology

Volumn 31, Issue 4, 2003, Pages 373-378

  Savransky, Vladimir ^a   Rostapshov, Victor ^a   Pinelis, Dmitriy ^b   Polotsky, Yury ^a   Korolev, Sergey ^a   Komisar, Jack ^a   Fegeding, Konstantin V ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Animal model; Histopathology; Immune system; Staphylococcal enterotoxin B; Superantigen; Toxic shock

Indexed keywords

STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRONCHOPNEUMONIA; CELL MIGRATION; FEMALE; GERMINAL CENTER; HISTOPATHOLOGY; LD 50; LETHAL DOSE; LETHALITY; LIVER NECROSIS; LUNG EDEMA; LYMPH FOLLICLE; LYMPHOCYTE; LYMPHOID CELL; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEPTIC SHOCK; SPLEEN; THYMUS; TOXICITY TESTING;

ADMINISTRATION, INTRANASAL; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROTOXINS; FEMALE; INTESTINES; KIDNEY; LETHAL DOSE 50; LIVER; LUNG; MICE; SHOCK, SEPTIC; THYMUS GLAND;

ANIMALIA; MACACA MULATTA; MURINAE; STAPHYLOCOCCUS;

EID: 0012893150     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230309725     Document Type: Article

References (44)

1. Anderson MR, Tary-Lehmann M (2001). Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment. Clin Immunol 98(1): 85-94.
2. Assenmaher M, Lohning M, Scheffold A, Manz RA, Schmitz J, Radbruch A (1998). Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes. Eur J Immunol 28(5): 1534-1543.
3. Baccala R, Vandekerckhove BA, Jones D, Kono DH, Roncarolo MG, Theofilopoulos AN (1993). Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model. J Exp Med 177(5): 1481-1485.
4. Beisel WR (1972). Pathophysiology of staphylococcal enterotoxin, type B, (SEB) toxemia after intravenous administration to monkeys. Toxicon 10(5): 433-440.
5. Benjamin MA, Lu J, Donnelly G, Dureja P, McKay DM (1998). Changes in murine jejunal morphology evoked by the bacterial superantigen Staphylococcus aureus enterotoxin B is mediated by CD4+ T cells. Infect Immun 66(5): 2193-2199.
6. Berg MS (1983). Enterotoxins. In: Staphylococci and Staphylococcal Infections, Easmon CSF and Adams C (eds). vol. 2. Academic Press, Ltd., London, pp. 187-243.
7. Blank C, Luz A, Bendigs S, Erdmann A, Wagner H, Heeg K (1997). Superantigen and endotoxin synergize in the induction of lethal shock. Eur J Immunol 27(4): 825-833.
8. Center for Disease Control (1981). Food-borne outbreaks. Annual Summary 1981. Center for Disease Control. Atlanta.
9. Chen JY, Qiao Y, Komisar JL, Baze WB, Hsu IC, Tseng J (1994). Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun 62(10): 4626-4631.
10. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989). Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Nat Acad Sci USA 86(22): 8941-8945.
11. Datta S, Bhattacharyya P (2001). Effect of an herbal protein CI-1, purified from Cajanus indicus on the ultrastructural study of hepatocytes, in models of liver failure in mice. J Ethnopharmacol 77(1): 2001.
12. Fujiki M, Shinbori T, Suga M, Miyakawa H, Ando M (1999). Role of T cells in bronchoalveolar space in the development of interstitial pneumonia induced by superantigen in autoimmune-prone mice. Am J Respir Cell Mol Biol 21(6): 675-683.
13. Johnson HM, Russell JK, Pontzer CH (1991). Staphylococcal enterotoxins microbial superantigen. FASEB J 5(12): 2706-2712.
14. Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, Boylston L, Carrel S, Posnett DN, Choi Y, Marrack P (1989). V-beta specific stimulation of human T cells by staphylococcal toxins. Science 244(4906): 811-813.
15. Khullar M, Chatterjee S (1995). Staphylococcal enterotoxin-B (SEB) alters [14C]-choline transport and phosphatidylcholine metabolism in cultured human kidney proximal tubular cells. Mol Cell Biochem 146(2): 115-20.
16. Komisar J, Rivera J, Vega A, Tseng J (1992). Effects of staphylococcal enterotoxin B on rodent mast cells. Infect Immun 60(7): 2969-2975.
17. Komisar JL, Weng CF, Oyejide A, Hunt RE, Briscoe C, Tseng J (2001). Cellular and cytokine responses in the circulation and tissue reactions in the lung of rhesus monkeys (Macaca mulatta) pretreated with cyclosporin A and challenged with staphylococcal enterotoxin B. Toxicol Pathol 29(3): 369-378.
18. Kortepeter MG, Parker GW (1999). Potential Biological Weapons Threats. Emerg Infect Dis 5(4): 523-527.
19. Leist M, Gantner F, Naumann H, Bluethmann H, Vogt K, Brigelius-Flohe R, Nicotera P, Volk HD, Wendel A (1997). Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology 112(3): 923-934.
20. Lin YS, Huang YT, Chen PS, Lin CF, Jan MS, Lei HY (1999). Requirement of I-E molecule for thymocyte apoptosis induced by staphylococcal enterotoxin B in vivo. Cell Immunol. 193(1): 71-79.
21. Lin YS, Lei HY, Low TL, Shen CL, Chou LJ, Jan MS (1992). In vivo induction of apoptosis in immature thymocytes by staphylococcal enterotoxin B. J Immunol 149(4): 1156-1163.
22. Mattix ME, Hunt RE, Wilhelmsen CL, Johnson AJ, Baze WB (1995). Aerosolized staphylococcal enterotoxin B-induced pulmonary lesions in rhesus monkeys (Macaca mulatta). Toxicol Pathol 23(3): 262-268.
23. McKay DM (2001). Bacterial superantigens: Provocateurs of gut dysfunction and inflammation? Trends Immunol 22(9): 497-501.
24. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H (1992). T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J Exp Med 175(1): 91-98.
25. Nagaki M, Tanaka M, Sugiyama A, Ohnishi H, Moriwaki H (1999) Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. J Hepatol 31(5): 815-824.
26. Parrillo JE. (1993). Pathogenetic mechanisms of septic shock. N Engl J Med 328(20): 1471-1478.
27. Parrilo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP (1990). Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113(3): 227-242.
28. Perkins DL, Wang Y, Ho SS, Wiens GR, Seidman JG, Rimm IJ (1993). Superantigen-induced peripheral tolerance inhibits T cell responses to immunogenic peptides in TCR (beta-chain) transgenic mice. J Immunol 150(10): 4284-4291.
29. Raj HD, Bergdoll MS (1969). Effect of enterotoxin B on human volunteers. J Bacteriol 98(2): 833-834.
30. Rogers TJ, Zhang L (1997). Structural basis for the interaction of superantigen with the alternative superantigen-binding receptor p85. Mol Immunol 34(3): 263-272.
31. SAS Institute Inc. (1999). SAS/STAT User's Guide, Version 8, Cary, NC: SAS Institute Inc.
32. Schantz EJ, Roessler WG, Wagman J, Spero L, Dunnery DA, Bergdoll MS (1965). Purification of staphylococcal enterotoxin B. Biochem]istry 4(6): 1011-1016.
33. Schlievert PM (1986). Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1(8490): 1149-1150.
34. Shinbori T, Matsuki M, Suga M, Kakimoto K, Ando M (1996). Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B. Cell Immunol 174(2): 129-137.
35. Spiekermann GM, Nagler-Anderson C (1998). Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol 161(11): 5825-5831.
36. Stiles BG, Bavari S, Krakauer T, Ulrich RG (1993). Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: Major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun 61(12): 5333-5338.
37. Tessier PA, Naccache PH, Diener KR, Galdue RP, Neote KS, Clark-Lewis I, McColl SR (1998). Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-alpha. I Immunol 161(3): 1204-1211.
38. Tiegs G, Gantner F (1996). Immunotoxicology of T cell-dependent experimental liver injury. Exp Toxicol Pathol 48(5): 471-476.
39. Tseng J, Komisar J, Chen JY, Hunt RE, Johnson AJ, Pitt L, Rivera J, Ruble DL, Trout R, Vega A (1993). Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B. Infect Immun 61(2): 391-398.
40. Vabulas R, Bittlingmaier R, Heeg K, Wagner H, Miethke T (1996). Rapid clearance of bacterial superantigen staphylococcal enterotoxin B in vivo. Infect Immun 64(11): 4567-4573.
41. Weng CF, Zhao W, Fegeding KV, Komisar JL, Tseng J (1999). Resistance of Staphylococcal enterotoxin B-induced proliferation and apoptosis to the effects of dexamethasone in mouse lymphocyte cultures. Int Immunol 11 (5): 787-801.
42. Wood AC, Todd I (1995). Staphylococcal enterotoxin B toxicity in BALB/c mice: effect on T-cells, plasma cytokine levels and biochemical markers. FEMS Immunol Med Microbiol 11 (2): 91-97.
43. Wright SW, Trott AT (1988). Toxic shock syndrome: A review. Ann Emerg Med 17(3): 268-273.
44. Yeung RS, Penninger JM, Kundig T, Khoo W, Ohashi PS, Kroemer G, Mak TW (1996). Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: Supersensitivity to superantigen-induced septic shock. Eur J Immunol 26(5): 1074-1082.